Larsen GL and Henson PM |
Mediators of inflammation. |
1983 |
Annu. Rev. Immunol. |
pmid:6399978
|
Albert DH and Snyder F |
Biosynthesis of 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine (platelet-activating factor) from 1-alkyl-2-acyl-sn-glycero-3-phosphocholine by rat alveolar macrophages. Phospholipase A2 and acetyltransferase activities during phagocytosis and ionophore stimulation. |
1983 |
J. Biol. Chem. |
pmid:6401298
|
König W et al. |
On the biological role of lipid chemotactic factors. |
1983 |
Agents Actions Suppl. |
pmid:6404145
|
Ninio E et al. |
Biosynthesis of platelet-activating factor (PAF-acether). V. Enhancement of acetyltransferase activity in murine peritoneal cells by calcium ionophore A23187. |
1983 |
Biochim. Biophys. Acta |
pmid:6405792
|
Alam I et al. |
Human and rabbit platelets form platelet-activating factor in response to calcium ionophore. |
1983 |
Thromb. Res. |
pmid:6407140
|
Mencia-Huerta JM et al. |
Antigen-initiated release of platelet-activating factor (PAF-acether) from mouse bone marrow-derived mast cells sensitized with monoclonal IgE. |
1983 |
J. Immunol. |
pmid:6315819
|
Czarnetzki B |
Increased monocyte chemotaxis towards leukotriene B4 and platelet activating factor in patients with inflammatory dermatoses. |
1983 |
Clin. Exp. Immunol. |
pmid:6317241
|
Farr RS et al. |
Human serum acid-labile factor is an acylhydrolase that inactivates platelet-activating factor. |
1983 |
Fed. Proc. |
pmid:6628702
|
Tence M et al. |
The enantiomer and the positional isomer of platelet-activating factor. |
1983 |
Biochim. Biophys. Acta |
pmid:6824744
|
Denjean A et al. |
Acute effects of intratracheal administration of platelet-activating factor in baboons. |
1983 |
J Appl Physiol Respir Environ Exerc Physiol |
pmid:6629917
|
Camussi G et al. |
Biosynthesis and release of platelet-activating factor from human monocytes. |
1983 |
Int. Arch. Allergy Appl. Immunol. |
pmid:6826235
|
Tanaka S et al. |
Studies on the hypotensive effects of platelet activating factor (PAF, 1-O-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine) in rats, guinea pigs, rabbits, and dogs. |
1983 |
J. Pharmacobio-dyn. |
pmid:6668545
|
Saeki S et al. |
Hypotensive activity of 1-O-hexadecyl-2-O-acetyl-sn-glycero-3-phosphocholine in rats with various types of hypertension. |
1983 |
Med J Osaka Univ |
pmid:6669136
|
Valone FH and Goetzl EJ |
Specific binding by human polymorphonuclear leucocytes of the immunological mediator 1-O-hexadecyl/octadecyl-2-acetyl-sn-glycero-3-phosphorylcholine. |
1983 |
Immunology |
pmid:6848449
|
Chilton FH et al. |
Metabolic fate of platelet-activating factor in neutrophils. |
1983 |
J. Biol. Chem. |
pmid:6853486
|
Stormorken H et al. |
A new bleeding disorder: lack of platelet aggregatory response to adrenaline and lack of secondary aggregation to ADP and platelet activating factor (PAF). |
1983 |
Thromb. Res. |
pmid:6857589
|
Kloprogge E et al. |
Stimulus-response coupling in human platelets. Evidence against a role of PAF-acether in the "third pathway'. |
1983 |
Thromb. Res. |
pmid:6857605
|
Lecrubier C et al. |
Study of platelet aggregation induced by platelet activating factor (PAF) after administration of ticlopidine or aspirin. |
1983 |
Agents Actions |
pmid:6858789
|
Hubbard JW et al. |
Antihypertensive effects of I-hexadecyl-2-acetyl-sn-glycero-3-phosphocholine on plasma renin activity and catecholamine responses in spontaneously hypertensive rats. |
1983 |
Life Sci. |
pmid:6337313
|
Acharya SB and MacIntyre DE |
Platelet products and vascular PGI2 production. |
1983 |
Prostaglandins Leukot Med |
pmid:6338532
|